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Abstract. Overexpression of the B cell leukemia/lym- 
phoma-2 (bcl-2) gene has been shown to confer a sur- 
vival advantage on cells by inhibiting apoptosis. In epi- 
thelia, the bclo2 gene is also related to development and 
differentiation, and the protein is strongly expressed in 
the embryo in the epithelial cells of the developing 
mammary gland. To investigate directly the effect of 
bcl-2 on human epithelial cells, we used an amphotro- 
pic recombinant retrovirus to introduce the gene into 
nontumorigenic cell lines developed from luminal epi- 
thelial cells cultured from milk. Here we demonstrate 
that while bcl-2 overexpression does not directly induce 
the tumorigenic phenotype, it provides a survival ad- 
vantage to the mammary epithelial cells by inhibiting 
cell death at confluence or under conditions of serum 
starvation, bcl-2 can also affect the phenotype of the 
original epithelial cells, and promote epithelial-mesen- 
chymal conversion, accompanied by loss of the cell ad- 
hesion molecules E-cadherin and 0t2~l integrin. The 
extent of the epithelial-mesenchymal conversion varies 
with small differences in the phenotype of the parental 
line and with the level of expression of Bcl-2 and in 
some cases cell lines emerge with a mixed phenotype. 
The increased survival of Bcl-2--expressing cells at con- 
fluence results in multilayering, and the development of 
three- dimensional structures. Where a mixed pheno- 
type is observed these structures consist of an outer 
layer of polarized epithelial cells separated by a base- 
ment membrane-like layer from an inner mass of fibro- 
blastoid cells. Branching morphogenesis of bcl-2 trans- 
fectants is also observed in collagen gels (in the absence 
of fibroblast growth factors). The results strongly indi- 
cate that by increasing their survival under restrictive 
growth conditions, and by modifying the epithelial phe- 
notype, bcl-2 can influence the specific morphogenetic 
behavior of mammary epithelial cells. 
T 
HE B  cell leukemia/lymphoma-2  (bcl-2)  1 gene was 
identified while studying the t(14;18)  chromosome 
translocations which frequently occur in B cell leu- 
kemia and follicular lymphoma (Yunis et al., 1982; Tsuji- 
moto et al., 1984; Bakhshi et al., 1985; Clearly et al., 1986). 
bcl-2 expression confers a survival advantage to a variety 
of cell types including  lymphoid cells, fibroblasts, and neu- 
ronal cells by inhibiting apoptosis induced by growth fac- 
tor  deprivation  (Tsujimoto,  1989; Alnemri  et  al.,  1992; 
Baffy et al., 1993) or applied stress such as heat shock and 
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ethanol treatment (Deng and Podack, 1993). Cooperative 
expression of bcl-2 with c-myc, ras, or viral genes has been 
suggested to be important in cell immortalization and tum- 
origenesis (Vaux et al., 1988; Reed et al., 1990; Strasser et 
al., 1990; Fanidi et al., 1992). 
Recently, bcl-2 expression has been described in epithe- 
lial  cells  and  in various types of epithelial  malignancies 
(Lu et al.,  1993a; Leek et al.,  1994). The  expression of 
Bcl-2  in  epithelial  organs  is mainly  associated with cell 
populations capable of proliferation  (Hockenbery et al., 
1991; Lu et al.,  1993b) and with tissue development and 
morphogenesis. In the resting breast, Bcl-2 is expressed in 
some luminal epithelial cells (Nathan et al., 1994), and the 
level  of expression  shows  a  cyclic  variation  during  the 
menstrual cycle (Sabourin et al., 1994). In the developing 
fetal breast, Bcl-2 is expressed in the basal cell layer of the 
budding mammary gland.  Bcl-2 is also expressed at a high 
level in more than 70% of breast carcinomas and the ex- 
pression  has  been found  to be inversely related  to  the 
apoptotic cell index (Chan et al., 1993; Leek et al., 1994). 
These observations suggest that Bcl-2 expression may be 
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breast and possibly in the evolution of breast malignan- 
cies. However, there has been no direct demonstration of 
an effect of Bcl-2 overexpression on the behavioral prop- 
erties of the normal or malignant mammary epithelial cells. 
To investigate the effect of overexpression of bcl-2 on 
human mammary epithelial cells, we have used an ampho- 
tropic recombinant retrovirus to introduce the gene into 
nontumorigenic cell lines developed from mammary epi- 
thelial cells cultured from milk (Bartek et al., 1991). The 
original  cell  line  MTSV1-7  and  a  subclone  HB2  (Ber- 
dechevsky et al., 1994) both retain many features of the lu- 
minal  epithelial cells from which the majority of breast 
carcinomas develop. These cell lines  also undergo mor- 
phogenesis  in  collagen  gels  in  vitro  (Berdechevsky and 
Taylor-Papadimitriou,  1991;  Berdechevsky et  al.,  1994), 
thus allowing analysis of the effects of Bcl-2 overexpres- 
sion  on  these  parameters.  Analysis  of the  transfectants 
showed that although overexpression of Bcl-2 did not in- 
duce the tumorigenic phenotype, the transfectants grew to 
higher cell densities that resulted in the formation of mul- 
tilayers  and  three-dimensional  structures  at  confluence. 
Epithelial polarity was  also affected and an epithelial to 
mesenchyme transition was seen to varying degrees in the 
different clones. In some cases this led to a pleiotypic dif- 
ferentiation and formation of organ-like structure in dense 
culture on plastic.  Branching morphogenesis in collagen 
gels was also seen. The results suggest that overexpression 
of bcl-2 can provide survival advantages under normally 
restricted growth conditions and promote phenotypic and 
morphological differentiation of mammary epithelial cells. 
Materials and Methods 
Cell Culture 
The cell lines MTSV1-7 and HB2 (Bartek et al., 1991; Berdechevsky et al., 
1994) were grown in Dulbecco's modified Eagle's medium (DME) supple- 
mented with 10 ~g/ml insulin (Sigma Immunochemicals, St. Louis, MO), 
5 p~g/ml hydrocortisone  (Sigma),  0.3  pLg/ml glutamine  and  10%  FCS 
(GIBCO BRL, Gaithersburg, MD) (referred to as growth medium). The 
retroviral infectants derived from MTSV1-7 or HB2 were maintained in 
the same medium with the addition of 0.4 p,g/ml of puromycin (Sigma). 
Table I. Antibodies 
Development of Helper-free Amphotropic 
bcl-21Retrovirus Producer Cell Lines 
Amphotropic bcl-2/retrovirus producer cell lines were developed by infec- 
tion of AM12, an amphotropic packaging cell line, with an ecotropic bcl-2/ 
retrovirus based on the pBabe puro vector according to the method de- 
scribed by Morgenstern and Land (1990). Infected cells were selected with 
2  p,g/ml puromycin. The retroviral  titres of the isolated clones ranged 
from 105 to 106 colony-forming units (CFU)/ml as detected by titration for 
puromycin resistance on NIH 3T3 cells. The amphotropic bcl-2/retrovirus 
producer cell lines were grown to full confluence and the spent medium 
was replaced with half as much fresh medium. The virus-containing me- 
dium was harvested following 3-d incubation, filtered, quick-frozen in dry 
ice, and stored in aliquots at -70°C. 
Development of Human Mammary 
Epithelial Cell Lines Expressing bcl-2 and or the 
Puromycin-resistance Marker 
For infection of the epithelial cell lines, MTSV1-7 and HB2, 2 ml of viral 
stock (with or without dilution) containing 8 }xg/ml polybrene was added 
to each dish. Infection proceeded for 4 h and cells were cultured for 2 d 
before being split i  in 10 in selective medium (0.4 p.g/ml puromycin) until 
drug-resistant cells grew out. Individual colonies could only be identified 
when the viral stock were used as 1:10 or more dilution and ring cloned us- 
ing Wbatman filter paper soaked in trypsin/versine. Selected clones were 
referred to as MTSV1-7 B1 or HB2 B1 etc. Where a high concentration of 
virus  was  used,  most  cells  survived  selection  and  the  cultures  from 
MTSV1-7 were also expanded and the mixed culture studied here is re- 
ferred to as MTSV1-7Bcl-2. Ceils were also infected with an amphotropic 
retrovirus derived from the pBabe puro vector and the cell lines which 
were  derived  from  clones  are  referred  to  as  MTSV1-7Purol  etc.  or 
HB2Purol etc. The cell line derived from the MTSV1-7 mixed culture af- 
ter using a high multiplicity of infection is referred to as MTSV1-7Puro. 
The experiments were carried out in accordance with the British Advi- 
sory Committee for Genetic Manipulation/Health and Safety Executive 
Guidelines. 
Antibodies 
The name, specificity and source of antibodies (Ab) are listed in Table I. 
Immunofluorescence and Immunoperoxidase Staining 
Cells were grown on glass coverslips, washed with PBS, air-dried and fixed 
with methanol/acetone (1:1, precooled to 20°C) for 10 rain for cytoplasmic 
protein detection, and with 4% formaldehyde for 10 rain for membrane 
protein detection.  After blocking with 20%  FCS/PBS  for 30 rain, cells 
were incubated with appropriate first Ab and then detected with FITC- 
conjugated rabbit anti-mouse Ig (1:40; Dako Corp., Carpinteria, CA) or 
FITC conjugated sheep anti-rabbit Ig (1:40; Dako). 
Antibody  Antigen  Species  Dilution  Source (reference) 
bcl-2/124  Bcl-2  Mouse  1:50 
HECD- 1  E-cadherin  Mouse  1:100 
HAS4  ct2 integrin  Mouse  1:100 
J143  ct3 integrin  Mouse  1:20 
MAR4  131 integrin  Mouse  1:100 
LLOO2  Keratin 14  Mouse  Undiluted 
DA7  Keratin 18  Mouse  Undiluted 
BA16  Keratin 19  Mouse  Undiluted 
HMFG 1  PEM  Mouse  Undiluted 
HMFG2  PEM  Mouse  Undiluted 
Dako-vimentin  Vimentin  Mouse  1:100 
ZO- 1  ZO- 1 protein  Rabbit  1:100 
Collagen Type IV  Collagen Type IV  Rabbit  1:100 
Dako (Pezzella et al., 1990) 
Dr. M. Takeichi* (Shimoyama et al., 1989) 
Dr. F. Watt~t (Tenchini et al., 1993) 
Dr. A. Albino§ (Wayner and Carter, 1987) 
Dr. M. ColnaghiU (Pellegfini et al., 1992) 
(Leigh et al., 1988):~ 
Dr. J. Bartek (Lauerova et al., 1988) 
(Bartek et al., 1985):~ 
(Burchell et al., 1983)~: 
(Burchell et al., 1983):~ 
Dako (Osborn et al., 1984) 
ZYMED (Willott et al., 1992) 
Euro-Diagnostics (Visser et al., 1986) 
PEM, polymorphic epithelial mucin. 
* Kyoto University, Japan. 
~: Imperial Cancer Research Fund, London, UK. 
§ Sloan-Kettering Institute, New York. 
IDivision of Experimental Oncology, Istituto Nazionale Tnmori, Milan, Italy. 
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ture flasks with 20 mg/ml dispase (Boehringer Mannheim Corp., India- 
napolis, IN) and cell sheets were fixed with 10% neutral-buffered formalin 
and wax-embedded for paraffin sections, and then stained by H  & E  or 
with antibodies using the three step peroxidase anti-peroxidase (PAP) 
method. Following the first Ab, rabbit  anti-mouse Ig (1:20;  Dako)  or 
swine anti-rabbit Ig (1:100;  Dako), and then mouse PAP (1:50; Dako) or 
rabbit PAP (1:50; Dako) were applied. Peroxidase activity was developed 
with 3,3'-diaminobenzidine tetrahydrochloride (DAB, 1 mg/mi in PBS) 
and H202 (1 i~l/ml) and the cells were counterstained with haemotoxylin. 
Confocal Microscopy 
Cells were grown on 9-ram glass coverslips for immunofluorescence stain- 
ing as described above. Cells were mounted in glycerol/PBS solution and 
analyzed on a Nikon Optiphot Microscope viewing horizonal (Z-series) 
and vertical (XZ-series) sections through the cells. 
Fluorescence  Activated Cell Sorting Analysis 
Cells grown to confluence were harvested by trypsinization and washed 
with 5% FCS/PBS. The suspended cells were incubated with first Ab for 
45 rain, washed twice, and then incubated with FITC-conjugated rabbit 
anti-mouse Ig (1:40;  Dako) for an additional 45 rain. Finally, cells were 
washed and resuspended in i  ml PBS. All steps were carded out at 4°C af- 
ter trypsinization. A minimum of 5,000 cells were analyzed using a FAC- 
Scan flow eytometer (Becton-Diekinson, Cockeysville, MD). 
Growth and Survival Assays 
Subconfluent growing cells were suspended by trypsinization and for each 
cell line, 1 ×  l0  s cells were plated in 6-crn culture dish in triplicate in DME 
supplemented with 10, 2, or 1% FCS. Medium was changed every 3 d and 
the number of attached cells counted at day 3, 6, 9,15, and 18. 
To evaluate cell death at confluence, floating cells in culture medium, 
indicative  of epithelial  cell  death,  were  collected  at  time  of medium 
changes (days 9, 15, and 18). Since the number of dead cells was difficult 
to be determined accurately due to degradation, DNA was instead ex- 
tracted  from the floating cells by phenol-chloroform and measured by 
spectrophotometry. 
Electron Microscopy Examination 
Floating cells from supernatant after confluence were pelleted and fixed 
with glutaraldehyde (2.5% wt/vol in 0.1 M  Soreusen's phosphate buffer, 
pH 7.4) for 2 h  at room temperature. The pellets were washed with the 
buffer and postfixed in 1% osmium tetraoxide for an hour. Samples were 
dehydrated and embedded in araldite  resin (Taab Laboratories Equip- 
ment Ltd., Alder Maston, UK). 100-nm sections were mounted on carbon/ 
formvar-coated grids and stained with uranyl acetate for 10 rain followed 
by saturated lead citrate for 4  min before being examined using a  Jeol 
1200 transmission electron microscope. 
Assay for Anchorage-independent Growth 
and Tumorigenicity 
For each cell line, 2 ×  104 cells were seeded in 0.3% agar on top of a 0.5% 
agar base in 6-cm culture dish in duplicate. The cultures were maintained 
in growth medium changed every 3 d for 3 wk. T47D, a breast carcinoma 
cell line was used as positive control. 
To assess the tumorigenicity, 1 ×  107 cells per site were injected subcu- 
taneously in nu-nu mice. For each cell line four mice were implanted at 
two sites per mouse. The mice were monitored for 3 mo. eel, a cerbB-2 
transformed tumorigenic cell line originated from MTSV1-7 (D'Souza et 
al., 1993), was used as tumor control. 
Cell Growth in Collagen Gel 
2 ×  104 cells were suspended in 2 ml of neutralized isotonic bovine dermal 
collagen (Vitrogen 100; Imperial Laboratories Ltd., Andover, Hants, UK) 
according to manufacturer's instructions. The mixture was poured into 
3-cm tissue culture dishes and incubated at 37°C for 2 h to gel Medium 
was then added and the cells allowed to grow for 2 wk. 
Probes and Northern Blot Analysis 
A  950-bp EeoRI fragment of bcl-2 eDNA, 4.5-kb XbaI/KpnI fragment of 
the ct2 integrin eDNA, 2.6-  and 0.6-kb EeoRI fragments of E-eadherin 
eDNA  and  a  330-bp  fragment of vimentin eDNA  were  labeled  with 
[32p]dCTP  (Amersham Corp., Arlington Heights, IL) by random priming 
and used as probes for appropriate mRNA detection. 
Total cellular RNA from the cell fines was isolated according to the 
method of Chomezynski and Saeehi (1987). 25 p.g of RNA from each cell 
line was denatured in 1 ×  MOPS buffer, containing 0.66 M formaldehyde 
and 50% (vol/vol) formamide, run on a  1.2% agarose-formaldehyde gel, 
and  transferred  onto  membranes (Hybond-N;  Amersham). The  mem- 
brane-bound RNA was hybridized to labeled probe according to the pro- 
toeol  described by Church and Gilbert  (1984).  Hybridization was per- 
formed in 0.2 M sodium phosphate, pH 7.2, 0.1 M EDTA, 7% SDS, 45% 
formamide and 250 p~g/mi  denatured salmon sperm DNA at 42°C for 16 h. 
The filters were sequentially washed twice with 0.5%  SSC/0.1%  SDS at 
65°C for 20 min and 0.1% SSC/0.1% SDS at 65°C for 20 rain. Filters were 
exposed to Fuji film at 70°C. To assess the loading of RNA, the mem- 
branes were reprobed for the glyceraldebyde-3-phosphate dehydrogenase 
gene. 
Western Blot Analysis of  Protein Expression 
The level of expression of Bcl-2 and E-cadherin was assessed by subject- 
ing 100 ~g of total cell lysates to immunoblot analysis. Confluent cell cul- 
tures were washed with complete PBS and lysed in HNET buffer (50 mM 
Hepes, pH 7.5, 100 mM sodium chloride, 1 mM EGTA, 1% Triton X-100, 
1 mM dithiothreitol, and I mM PMSF) for Bcl-2 detection, and in HNET 
buffer containing 1 mM calcium chloride for E-cadherin detection. After 
clarification of the lysates by centrifugation at 15,000 g for 10 min at 4°C, 
the protein concentration of the lysates was estimated using the Bio-Rad 
protein assay kit  (Bio-Rad Labs., Richmond, CA).  Samples were  then 
electrophoretically separated on a 5% stacking/12.5% running SDS-poly- 
acrylamide gel for Bcl-2 detection and on a  5%  stacking/7.5% running 
SDS-polyacrylamide gel for E-eadherin detection. Immunoblots for Bcl-2 
were blocked with 5 % BSA and 0.1% Tween 20 in PBS (blocking buffer) 
for 2 h followed by incubation with Ab bcl-2/124 (1:50)  at room tempera- 
ture for one hour. Immunoblots for E-cadherin were blocked with 5% 
skimmed milk and 1% BSA in complete PBS (blocking buffer) for 3 h fol- 
lowed by incubation with Ab HECD-1 (1:100)  in blocking buffer at 4°C 
overnight. The  first  Abs were  detected  using 125I-labeled  sheep  anti- 
mouse Ig (0.5 ~ci/ml). 
Transfections and CAT Activity Assays 
The chloramphenicol acetyl transferase (CAT) constructs containing the 
E-cadherin regulatory sequences (p0.2CAT and p6.5CAT) were kindly 
provided by Dr. J. Behrens (Delbruck Centre, Berlin, Germany), the con- 
trol plasmid, pGCAT-A, by Drs. T. Frebourg and O. Brison (Laboratory 
of Molecular Oneology Institute, Gustave Roussy, France). p J3 Lue con- 
taining the luciferase gene driven from the SV40 promoter was obtained 
from Dr. S. Goodbourn (St. Georges Medical Hospital, London, UK). 
Cells (2 x  105) were plated on 6-cm plates and incubated overnight and 
then  transiently transfected  by  the  calcium phosphate  coprecipitation 
method  as  previously  described  (D'Souza  and  Taylor-Papadimitriou, 
1994).  10 v,g of the CAT plasmid together with 2 i~g of the inciferase ex- 
pression plasmid, p J3 Luc, were used for each 6-cm dish in duplicate for 
each sample in individual experiments. Trausfection was carried out for 
12  h and the precipitate removed by repeated washing of the cells with se- 
rum-free medium before replacing with fresh medium. Cells were grown 
for 48 h after transfection, and then lysed in 200 wl of NP-40 buffer (0.65% 
NP-40, 10 mM Tris-HC1, pH 8.0, 1 mM EDTA, and 150 mM NaC1). 30 wl 
of lysate was incubated at 68°C for 10 rain and the CAT activity was as- 
sayed essentially as described previously (Kovarik et al., 1993).  CAT ac- 
tivities have been expressed as the ratio of the CAT activity (counts/rain/ 
2 h) to luciferase activity (arbitrary units of chemiluminescence). 
Results 
Isolation of Clones of MTSV1-7 and HB2 Cells 
Overexpressing the bcl-2 Gene 
MTSV1-7 is a cloned cell line originally developed by im- 
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Expression  Expression 
Cell lines  of Bcl-2  Cell lines  of Bcl-2 
From mixed cultures 
MTSV 1-7Bcl-2"  Moderate 
MTSV l-7Puro;  Negative 
From single clones 
MTSV 1-7 B 1"  Low 
MTSV 1-7 B7*  High 
MTSV 1-7 B 10*  High 
MTSV1-7 Puro 3:~ 
MTSV1-7 Puro 14:~ 
HB2 B4* 
HB2 B6* 
HB2 B9* 
HB2 B12* 
HB2 B17* 
HB2 Puro2~: 
HB2 Puro4:~ 
HB2 Puro8~ 
High 
Moderate 
Low 
High 
High 
*Cells infected with recombinant amphotropic virus expressing Bcl-2 and the puro- 
mycin resistance markers. 
:~ Cells infected with recombinant amphotropic virus expressing puromycin resistance 
marker only. 
mortalizing cells cultured from human milk with SV40TAg. 
The cells are non tumorigenic, do not show anchorage in- 
dependent growth and reflect the phenotype of the lumi- 
nal epithelial cell in the profile of keratins they express (7, 
8, 18, and 19) and in their expression of an epithelial mucin 
(polymorphic  epithelial  mucin  [PEM])  (Bartek  et  al., 
1991). In collagen gels, MTSV1-7 cells form ball-like struc- 
tures,  a  fraction  of which  can  be  induced  to  branch  by 
hepatocyte growth factor or other flbroblast-derived growth 
factors  (Berdechevsky et  al.,  1992,  1994).  The  HB2  cell 
line  is  a  subline  of MTSV1-7  selected  in  collagen  for  a 
more homogeneous branching response to fibroblast-derived 
Figure 1.  Analysis of the levels of bcl-2 mRNA and protein in the 
HB2 clones. Northern blot showing major transcripts  of 5.5 kb in 
the bcl-2  transfectants,  but not in the parental and puro vector 
control cell lines (upper panel). Western blot showing expression 
of Bcl-2 protein (lower panel). 
Figure 2.  Detection of Bcl-2 protein by immunofluorescent stain- 
ing with Ab bcl-2/124. (A) MTSV1-7Puro cells show staining only 
in a few cell nuclei. (B) A diffuse cytoplasmic staining is observed 
in nearly all cells of MTSV1-7 B7 clone. Bar, 25 txm. 
factors. Since these factors can also affect cell proliferation, 
HB2  cells  grow  to  a  higher  cell  density  than  MTSV1-7 
cells. Both cell lines exhibit well-defined epithelial polarity 
showing apical expression of PEM and sub-apical and lat- 
eral localization of the ZO-1 and E-cadherin components, 
respectively (see below). 
Because epithelial cells are difficult to transfect, an am- 
photropic retrovirus  was developed expressing the  bcl-2 
gene  from  an  LTR  promoter  and  a  selectable  marker 
(puromycin resistance) under the control of the SV40 pro- 
moter.  Cells  were  also  infected  with  a  virus  expressing 
only the selectable puromycin resistance marker for isola- 
tion of control cell lines. Infection was extremely efficient 
and single clones could only be isolated from cultures in- 
fected with low concentrations  of virus. At higher multi- 
plicities of infection, most cells survived puromycin selec- 
tion and in the case of the MTSV1-7 cell line, these mixed 
cultures  were  also  expanded  and  used  in  some  studies 
(MTSV1-7Bcl-2 or MTSV1-7Puro). Table II lists the vari- 
ous cell lines which were isolated and characterized. 
Analysis of the levels of Bcl-2 protein and mRNA in the 
clones showed that there was in fact little correlation be- 
tween the level of mRNA detected by Northern blots and 
the level of Bcl-2 protein detected by Western blots and 
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MTSV1-7 and HB2. Cells plated at 1 x 
105  per  6-era dish were  cultured  in 
growth medium  containing  10%  FCS 
(A, C, and E) or medium with 2% FCS 
(B and D) and 1% FCS (F). A and B 
show the  growth curves of the  mixed 
culture.  C,  D,  and  F  shows the  cell 
number of individual clones after 18 d 
of culture. The number  of ceils repre- 
sents  means  of experiments  in  tripli- 
cate. E shows the amount of DNA ex- 
tracted  from floating cells of cultured 
supernatants at days 9, 15, and 18 when 
the medium was changed in the experi- 
ment shown in A. The amount of DNA 
shown on the ordinate  is expressed as 
Ixg per 10  6 attached cells. 
this is illustrated  for the HB2 cloned cell lines in Fig.  1. 
The discrepancy was particularly evident in HB2 B9 which 
showed the highest mRNA level, but the lowest expres- 
sion of the protein.  The Bcl-2 protein was detected  as a 
diffuse cytoplasmic stain by indirect immunofluorescence 
and this is illustrated for the MTSV1-7 B7 clone in Fig. 2 
B. In the cell lines showing a high protein expression, 90% 
of the cells showed a high level of staining. In cell lines ex- 
pressing low levels of the Bcl-2 protein (e.g.,  MTSV1-7B1 
and HB2 B9) staining was more heterogeneous with only 
~10% of cells showing strong staining, and the remainder 
staining positively but weakly. Parental cell lines,  and lines 
expressing only the puromycin selectable marker did not 
show cytoplasmic staining but, as we have observed for im- 
mortalized cell lines (Lu et al., 1994), mitotic cells showed 
nuclear staining (Fig. 2 A). 
Growth Properties of bcl-2 Transfectants 
Since bcl-2 has been found to extend the life span of cells 
by inhibiting apoptosis, the growth properties of the bcl-2 
transfectants were examined. Overexpression of the gene 
in MTSV1-7 or HB2 cells did not induce the tumorigenic 
phenotype  as  defined  by either  anchorage  independent 
growth in vitro or formation of tumors in the nude mouse. 
However, the bcl-2 transfectants did exhibit different prop- 
erties when grown on plastic. The mixed culture of Bcl-2- 
expressing MTSV1-7 cells  was found to grow to a higher 
cell density in growth medium containing 10% serum than 
that seen with either the parental cell line or with the cell 
line MTSV1-7Puro (from a mixed culture) (Fig. 3 A). Also 
the MTSV1-7Bcl-2 cells were able to proliferate and main- 
tain cell numbers at higher levels in only 2% serum (Fig. 3 
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bodies. Bar, 5 p.m. 
B). The effect of bcl-2 expression on the growth of individ- 
ual  clones  in  medium containing  10  and  2%  serum was 
also examined (Fig. 3, C and D). Small but significant in- 
creases in cell number at confluence were observed, par- 
ticularly  with  the  clones  expressing high  levels of Bcl-2 
(MTSV1-7 BT, B10, HB2 B6, and B12; Table II and Fig. 
1). All of the puromycin resistant lines listed in Table II 
were examined and the data shown in Fig. 3, C and D  are 
for one example each of the MTSV1-7- and HB2-derived 
lines. The puromycin resistant clones showed a smaller in- 
crease in cell numbers at confluence in low and high serum 
as compared to the bcl-2 transfectants. 
The HB2 transfectants could survive in 1%  serum (al- 
though MTSV1-7 cells and its transfectants could not). A 
more dramatic effect of overexpressing Bcl-2 in HB2 cells 
was  seen  on  the  survival of two  high  expressing  clones 
(HB2 B6 and B12) grown in this low serum concentration. 
Fig. 3 F  illustrates this point and also shows that none of 
the  three  puromycin transfectants  of HB2  cells  showed 
such an effect. The HB2 B9 clone which expressed low lev- 
els of Bcl-2 (see Fig.  1)  did not  show increased  survival 
compared to the puromycin clones. 
The  MTSV1-7  and  HB2  are  immortal  cell  lines  and 
when  proliferating  in  sub-confluent  cultures  in  normal 
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growth of cells on plastic af- 
ter confluence. (A) MTSV1- 
7; (B) MTSV1-7 B7; (C) HB2; 
(D) HB2 B12. Both parental 
lines MTSV1-7  and HB2 grow 
as  monolayers.  The  bclo2 
transfectant  MTSV1-7 B7 
forms  multilayers  (B)  and 
HB2  B12  cells  pile  up  to 
form islands (D).  Cells were 
cultured  in  growth  medium 
for two weeks. Bar, 60 ~m. 
growth  medium  do  not  undergo  significant  cell  death. 
However after confluence or in low serum concentration, 
floating cells were detected in the culture medium. Mor- 
phological examination by electron microscopy of cells in 
the supernatant from the MTSV1-7 parental cell showed 
nuclear fragmentation and the presence of apoptotic bod- 
ies (Fig. 4). A possible explanation for the increase in cell 
numbers seen at confluence in transfectants overexpress- 
ing Bcl-2 is that fewer cells were detaching from the mono- 
layer. Cell numbers in the supernatants from MTSV1-7 bcl-2 
transfectants were therefore compared with those found in 
the parental MTSV1-7 cells or in MTSV1-7Puro cultures 
by measuring  DNA  in  cells pelleted from the  superna- 
tants, and the data corresponding to the experiment shown 
in Fig. 3 A  are shown in Fig. 3 E. The data clearly show 
that more cells are shed into the medium in the MTSV1-7 
or the MTSV1-7Puro cultures than in the MTSV1-7Bcl-2 
cultures. The increased numbers of cells in the superna- 
tants from the puromycin resistant line as compared with 
the parental line may be due to a slightly increased prolif- 
eration rate at confluence, resulting in increased shedding 
and cell death. Although the cells in the supernatants from 
MTSV1-7 and MSTV1-7Puro ceils show nuclear fragmen- 
tation and the apoptotic bodies seen in cells dying by apop- 
tosis, we could not detect the characteristic ladder of frag- 
mented  DNA  by  electrophoresis  (data  not  shown). 
Whatever the mechanism involved in the cell death occur- 
ring  at  confluence or  under  serum  deprivation,  overex- 
pression of Bcl-2 appears to protect the epithelial cells and 
allows them to grow and maintain a  higher density after 
confluence. 
In  the  bcl-2  transfectants  the  higher cell density after 
confluence was accompanied by the formation of multilay- 
ers  in  contrast  to  the  parental  cell  line  which  grew  as 
monolayers (Fig. 5). Moreover, in some cases, cells in the 
multilayers could develop into ball-like structures which 
showed morphological differentiation (see below). All the 
puromycin transfectants listed in Table II behaved like the 
parental cell lines in forming only monolayers at conflu- 
ence indicating that the changes in growth characteristics 
are likely to be due to overexpression of the bclo2 gene. 
Changes in Epithelial Phenotype Induced by 
Overexpression of bcl-2 
Several  studies  have  shown  that  loss  of  the  epithelial 
phenotype can be  induced by overexpression of certain 
oncogenes (Reichman et al.,  1992;  D'Souza and Taylor- 
Papadimitriou, 1994).  We therefore examined the epithe- 
lial polarity of the bcl-2 transfectants as well as the level of 
expression of molecules relating to the epithelial pheno- 
type. Immunofluorescent staining of subconfluent cells with 
specific antibodies showed that not only was there a reduc- 
tion in the expression of epithelial-related molecules but 
this was accompanied by the appearance of vimentin, an 
intermediate filament protein of mesenchymal cells. The 
most dramatic changes were seen in the MTSV1-7 B7 and 
B10 clones and the MTSV1-7Bcl-2 line, where most cells 
were found to express high levels of vimentin, and only a 
few cells showed expression of keratin 19 or E-cadherin. 
These cell lines showed a fibroblastic morphology. In the 
HB2 clones  and  the  MTSV1-7  B1  clone,  most  cells re- 
tained the epithelial phenotype, and only a few cells could 
be seen to  express vimentin, the fraction being greatest 
(,'-40%) in the HB2 B9 clone. All of the puromycin trans- 
fectants listed in Table II (and a further eight clones exam- 
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staining  of MTSV1-7Puro14 
(A,  C,  E,  and  G)  and 
MTSV1-7  B7  (B, D,  F,  and 
H).  Cells were  stained with 
Ab  BA16  to  CK19  (A  and 
B),  HECD-1  to  E-cadherin 
(C and D), HMFG2 to PEM 
(E and F), and with the Ab 
Dako-vimentin  to  vimentin 
(G  and  H).  Keratin  19  is 
strongly expressed in the con- 
trol cells (A), whereas the ma- 
jority of the B7 cells show loss 
of expression (B).  Similarly, 
peripheral  localized  E-cad- 
herin is demonstrated in the 
control cells (C).  In  the  B7 
cells,  the  expression  of  the 
protein can still be seen in a 
few  cells but  with  distorted 
distribution (D). PEM is ex- 
pressed strongly in  the  con- 
trol purotransfectant (E), but 
not  in  the  B7  cells  (F).  In 
contrast, only single cells ex- 
pressing vimentin are seen in 
the  control  cell  line  (G), 
while  the  B7  cells  become 
strongly positive for vimentin 
(H). Bar, 20 Ixm. 
ined but not listed) retained the epithelial phenotype ex- 
hibited  by  the  parental  cell  lines,  and  did  not  express 
vimentin. 
The differences between the B7 clone and the puro vec- 
tor transfectant  clone, MTSV1-7Purol4,  as seen by indi- 
rect immunofluorescent staining are illustrated in Fig. 6. In 
the case of the B7 clone the rare examples of expression of 
keratin 19 or E-cadherin have been selected to illustrate 
that even when expression can be detected, its distribution 
is abnormal. Similarly the single cell expressing vimentin 
rarely seen in the parental line and in the MTSV1-7Puro 
clone has been selected for illustration. In the MTSV1-7 
B7  and  B10  clones  the  changes  in  expression of E-cad- 
herin  and  vimentin  could  also  be  seen  at  the  level  of 
mRNA  and protein by Northern and Western blot analy- 
sis. Fig. 7  illustrates this and also the lack of vimentin ex- 
pression in the parental cell lines, and in the puro transfec- 
tant which express high levels of E-cadherin and keratin 
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Constructs  Transfected cells  CAT/Luc  Fold/increase 
pGCAT-A  MTSV 1-7 neo  45  1.0 
MTSV1-7 B7  52  1.0 
0.2 E-cadherin  MTSV1-7 neo  408  9.1 
MTSV1-7 B7  248  4.7 
6.5 E-cadherin  MTSV1-7 neo  121  2.7 
MTSV1-7 B7  48  0.9 
Cells were transfected with p  J3 Luc and one of the CAT reporter constructs: pGCAT- 
A (promoterless CAT construct), p6.5 CAT (containing 6.5 kb of mouse E-cadherin 
5' upstream sequence) or p0.2 E-cadherin (containing the -178/+17 E-cadherin pro- 
moter fragment). CAT activities are expressed as the ratio of CAT activity (counts/ 
min/2 h). Luciferase activity (arbitrary units of chemiluminescence). The ratios ob- 
tained are expressed as an increase over that obtained with pGCAT-A. 
19. Expression of keratin 18 was maintained in all the cells 
in the transfectants of both HB2 and MTSV1-7 although 
the level was lower in the vimentin-expressing cells (data 
not shown). 
The effect on polarity of the B7 cells is illustrated in Fig. 8 
where it can be seen that although some expression of the 
tight junction-associated  protein  ZO-1  is  seen, the  topo- 
graphical distribution is disorganized and the cells form mul- 
tilayers (Fig. 8, E and F). Moreover, even with the MTSV1-7 
B1 clone that expressed reasonable levels of the epithelial 
markers including ZO-1, the distribution of the marker is 
already changing. Fig. 8,  C and D  show that the distribu- 
tion of ZO-1 in the B1 clone is not as restricted as it is in 
the Puro14 cell line (Fig. 8, A  and B). 
We  have  recently  found  that  overexpression  of  the 
c-erbB2  proto-oncogene  in  MTSV1-7  cells  inhibited  ex- 
pression of the et2 integrin subunit in association with re- 
duced  expression  of  E-cadherin  (D'Souza  et  al.,  1993; 
D'Souza and Taylor-Papadimitriou, 1994). This is an inter- 
esting observation since the ot2B1 integrin function is in- 
volved in  the  in  vitro morphogenesis  of MTSV1-7  cells 
(Berdechevsky et  al.,  1992,  1994).  We now find  that  ex- 
pression of the a2 integrin subunit is also reduced in the 
Bcl-2 overexpressing MTSV1-7 cells (Fig. 9). This reduc- 
tion is correlated to the proportion of fibroblastoid cells, 
and as with the c-erbB2 transfectants, the effect was spe- 
cific for the ct2 integrin subunit, and was not seen with the 
et3 or [31 subunits. In the two MTSV1-7 clones, B7 and B10 
where  the  effect  on  the  epithelial  phenotype  is  most 
marked, the changes in expression of the a2 integrin sub- 
unit could be seen at the level of mRNA (illustrated for B7 
in Fig. 7). In the B1 clone where only a small proportion of 
cells showed the change to the mesenchymal phenotype, 
the  reduction  in  expression  was  only seen  in  a  subpop- 
ulation of cells (Fig. 9). The levels of the or2 integrin sub- 
unit in the Puro control lines was the same as that seen in 
the parental cell lines (illustrated for MTSV1-7Puro14 in 
Fig. 9). 
Reduction in Transcription of  E-cadherin in the 
MTSV1-7 B7 Clone 
Studies  with  the  c-erbB2  transfectant  of MTSV1-7  cells 
have shown that the reduction in expression of E-cadherin 
was due  to  inhibition  of transcription  of the  E-cadherin 
Figure 7.  Western blot for the detection of E-cadherin (A) and 
Northern  blots  for  detection  of mRNA  for  et2  integrin  (B), 
E-cadherin and vimentin (C). E-cadherin protein cannot be de- 
tected by MTSV1-7 B7 and B10 clones. The level of the protein 
in the B1 cell line is comparable to the parental and the vector 
control cell lines. The mRNA of E-cadherin and c~2 integrin sub- 
unit is detected in the parental, the puro vector control lines and 
the B1 clone, but not in B7 and B10 clones. In contrast, strong vi- 
mentin expression is only seen in B7 and B10 clones. 
gene.  To  see  whether  this  was  also  true  for  the  bcl-2- 
expressing clones, the E-cadherin promoter linked to a re- 
porter  gene  (chloramphenicol  transferase,  CAT)  were 
transfected into  the  B7  clone and  CAT expression com- 
pared  to  the  expression  seen in  an  MTSV1-7  neo  clone 
also transfected with the  CAT construct  (The neo trans- 
fectant was used since it proved to be impossible to trans- 
fect the MTSV1-7 puro clones). Table III shows the results 
of such an experiment that indicates that the E-cadherin 
promoter is less effective in driving CAT expression in the 
B7 clone. The decrease in transcription efficiency is ~50%. 
Pleiotypic Differentiation in Confluent Cultures 
of bcl-2 Transfectants 
As indicated above, morphologic and phenotypic analysis 
of the  bcl-2 transfectants  showed  that  the  cultures  con- 
tained two cell types with epithelial or fibroblastic charac- 
teristics, the proportion of each varying with the cell line, 
particularly  in  the  case  of  the  MTSV1-7  transfectants. 
Moreover, accumulation of cells at confluence resulted in 
the  formation of multilayers and  ball-like structures.  To 
examine the morphology and phenotype of the cells within 
these structures and the relation between the two types of 
cell, the cell layers were dislodged from the plastic (after 
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pression  on  cell  polarity as 
demonstrated by immunocyto- 
fluorescent staining for ZO-1 
protein and examined by con- 
focal microscopy.  (A,  C and 
E)  horizontal  sections;  (B, 
D,  and  F)  vertical  sections. 
(A and B) MTSV1-7Purol4; 
(C and D) MTSV1-7 B1; and 
(E and F) MTSV1-7 B7. ZO- 
1 expression is present around 
the  cell  boundary  (A)  and 
limited  to the upper part of 
the cell junctions  (B) in the 
MTSV1-7Puro14. Reduced ex- 
pression with  irregularity  in 
distribution  is seen in the B1 
clone (C and D). Expression 
of the protein is disorganized 
in the  multilayered B7  cells 
(E and F). Bar, 20 p.m. 
being in culture for 3 wk) rolled up and processed for par- 
affin sections. These sections showed that the parental cell 
lines and the puro vector control transfectants remained as 
monolayers with almost all the cells showing an epithelial 
phenotype. The  bcl-2  transfectants  however were  either 
predominantly epithelial  as with the  MTSV1-7 B1  clone 
and most of the HB2 clones, or predominantly fibroblastic 
as with the MTSV1-7 B7 or B10 clones. Both single layer 
and  multilayers were  seen with  the  B1  clone where  the 
majority  of  cells  retained  the  epithelial  phenotype,  ex- 
pressing mucin, keratin  19,  E-cadherin,  but no vimentin. 
However the  small ball-like  structures  which  developed 
showed a mixed population with fibroblast-like cells in the 
middle of the ball surrounded by epithelial cells. As illus- 
trated in Fig. 10, the outer layer of cells expressed E-cad- 
herin, keratin 19, and mucin, but no vimentin, while the in- 
ner  cells  showed  reduced  expression  of E-cadherin  but 
expressed  vimentin.  Mucin  was  expressed  by  both  cell 
types in this case. 
While the MTSV1-7 B7 only formed multilayers of cells 
with fibroblastic features, the bidirectional differentiation 
indicated in the B1  clone was most dramatically demon- 
strated in the mixed MTSV1-7Bcl-2 cell line. In the ball- 
like structures, the outer layer was composed of highly po- 
larized epithelial cells with E-cadherin localized between 
junctions and the mucin showing a marked apical location, 
while the inner mass of cells showed high expression of vi- 
mentin and a loss of expression of E-cadherin and mucin 
(Fig.  10).  Moreover  the  outer  cell  layer  was  separated 
from  the  inner  cell  mass  by  a  membrane-like  structure 
which could be visualised by staining with an antibody to 
type IV collagen (Fig. 11). 
The above results suggest that while Bcl-2 overexpres- 
sion protects the epithelial ceils from cell death, it can also 
affect their phenotype and differentiation. The pathway of 
cell differentiation appears to be affected by both levels of 
Bcl-2 expression, and the differentiation potential of the 
individual cells under a  given set of conditions. This sug- 
gestion is supported by the results from the Bcl-2-express- 
ing  HB2  lines.  Although  MTSV1-7  and  HB2  are  both 
cloned  cell  lines,  the  HB2  cells  are  more  homogeneous 
than  MTSV1-7  in  their  morphogenetic  phenotype  and 
Bcl-2 did not change this phenotype as significantly as it 
did the MTSV1-7 lines. 
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Figure 9.  FACS  analysis  of ct2  integrin  expression  using  Ab 
HSA4. A marked reduction of membrane el2 expression is seen 
in the B7 clone while only a proportion of B1 ceils show a re- 
duced expression of ct2 protein compared to the parental and the 
puro vector control cell lines. 
Formation of Structures in Collagen Gels 
The differences in the potential for morphological differ- 
entiation are also seen when the cell lines are grown in col- 
lagen gels. The parental cell lines form ball-like structures 
in collagen gels which can be induced to branch by fibro- 
blast-derived factors and the HB2 cells show a more uni- 
form smooth tubular branching response than the MTSV1-7 
cells. While the transfectants expressing the puromycin re- 
sistance gene also only formed ball-like structures (Fig. 12, 
A  and D), the cloned bcl-2 transfectants showed some de- 
gree of branching or spiking even in the absence of added 
factors. The most dramatic effect was seen with MTSV1-7 
B7 (Fig. 12 B) where most cells exhibit mesenchymal fea- 
tures with reduced expression of epithelial markers and in- 
creased  expression  of vimentin.  Although  the  form  of 
branching was different, it was also seen with the HB2 B9 
clone where  ~10%  of the  cells  exhibited mesenchymal 
features (Fig. 12 E). Sections of the structure in the gels 
showed the thinner branches to be made up of fibroblas- 
toid elongated cells, while the thicker branches (Fig. 12 E) 
were made up of epithelial like cells, in some cases sur- 
rounding a lumen (data not shown). The different form of 
branching  seen  with  Bcl-2-expressing  MTSV1-7  clones 
and Bcl-2-expressing HB2 clones, reflects the difference 
seen in the parental cell lines when they are grown in col- 
lagen gels in the presence of fibroblast-derived growth fac- 
tors (Berdechevsky et al., 1994). 
In correlating the changes in levels of the a2~l integrin 
with the patterns of morphogenesis seen in the bcl-2 trans- 
fectants, it becomes apparent that the function of the a2131 
integrin in morphogenesis in collagen is complex. Thus we 
have observed that the complete absence of function (in- 
duced by treatment with blocking antibodies) impairs cell- 
cell interactions and interferes with the formation of com- 
pact structures by HB2 cells. On the other hand the level 
of expression of the integrin is decreased in response to 
the collagen interaction (Berdechewsky et al., 1994). These 
observations suggest that while ot2131 integrin function is 
required for the formation of compact three-dimensional 
structures, a reduction in the level of the integrin may nor- 
mally accompany their formation possibly allowing some 
flexibility of movement of cells relative to each other. This 
is in keeping with the results reported here where the de- 
crease in et2~l expression is seen most dramatically with 
the  MTSV1-7  B7  transfectant,  which  gives  very  spiky 
branching structures that are not compact (Fig. 12 B). In 
contrast, the structures formed by the MTSV1-7 B1 trans- 
fectant, where only a fraction of the cells show reduced ex- 
pression of the  0t2131 integrin,  are  largely compact with 
some peripheral spiky branching (Fig. 12 C). 
It is possible  that  the  ability and  indeed the  form of 
branching in collagen may be related to the profile of ex- 
pression  of mesenchymal  characteristics,  particularly  of 
the intermediate filaments. This conclusion is supported 
by the results of an earlier study showing that hybrids of 
MTSV1-7 cells made with a vimentin-expressing cell line 
demonstrated  elongated  branching  structures  when  vi- 
mentin was the dominant intermediate filament of the hy- 
brid,  while  purely keratin-expressing hybrids developed 
ball-like structures (Berdechevsky and Taylor-Papadimi- 
triou, 1991). 
Since fibroblast derived factors are able to induce branch- 
ing in the parental cell lines, we tested whether the branch- 
ing of the bcl-2  transfectants could be attributed to the 
production of soluble factors by the cells themselves. How- 
ever, branching of the parental cell lines could not be in- 
duced by medium conditioned by the bcl-2 transfectants, 
MTSV1-7 B7  and B1, thus making this  explanation un- 
likely. We have also found that a reduction in the level 
or function of the ot3B1 integrin in HB2 cells resulted in 
branching of structures in collagen gels (Berdechevsky 
et al., 1994). Again however, no decrease in the level of 
the or3 integrin subunit was seen in the bcl-2 transfectants 
(data not shown). It seems therefore that the molecu- 
lar  mechanisms  involved in  Bcl-2-induced branching  of 
MTSV1-7 or HB2 cells are different from those previously 
reported. 
Discussion 
In the present study, we demonstrate that although bcl-2 
overexpression does not induce the  tumorigenic pheno- 
type, it provides a survival advantage to mammary epithe- 
lial cells under both standard culture conditions when cells 
are grown to confluence, and under conditions of serum 
starvation. This effect appears to be correlated with the 
level of Bcl-2 protein although other factor(s) may modify 
the effect, bcl-2 can also affect the phenotype of the origi- 
nal  epithelial cells,  and depending  on the  extent of the 
conversion to a mesenchymal type cell, this can lead to the 
emergence of a  mixed phenotype. The accumulation of 
cells at confluence leads to multilayering and to the devel- 
opment of structures where pleiotypic differentiation can 
occur. The bcl-2 transfectants also formed branching struc- 
tures in collagen gels which correlated with the changes in 
epithelial phenotype. The results suggest that while inhib- 
Lu ¢t al. bcl-2 and Mammary Epithelial Differentiation  1373 Figure lO.  •mmun•hist•chemi•a•  ana•ysis  •f  structures f•rmed  after c•nf•uence.  MTSV•-7Pur••  •eft pane•s;  MTSV1-7Bcl-2•  middle pan- 
els; MTSV1-7 B1, right panels. Immunostaining for Bcl-2 (row A), PEM (row B), vimentin (row C), and E-cadherin (row D). The ball- 
like structures in MTSV1-7Bcl-2 (middle panels) and B1 (right panels) consist of epithelial cells covering the surface and fibroblastoid 
cells in the inner ball. Both types of cells are Bcl-2 positive. PEM detected with Ab HMFG1 is apically expressed in the epithelial cells of 
the ball-like structure in MTSV1-7Bcl-2, but not in the inner fibroblastoid ceils. However both epithelial and inner fibroblastoid cells ex- 
press PEM in the B1 clone. Vimentin expression is restricted to the inner fibroblastoid cells in MTSV1-7Bcl-2 and B1 clones. E-cadherin 
expression is clearly demonstrated between cell junctions of the surface epithelial cells in MTSV1-7Bcl-2, but is distorted in B1 epithe- 
lial cells. Cells were cultured for 3 wk. Bar, 25 p,m. 
The Journal of Cell Biology, Volume 129, 1995  1374 Figure  11.  Immunoperoxidase  staining  of  a  section  from 
MTSV1-7Bcl-2 (from the same block as those in Fig. 10) for type 
IV collagen.  In the ball-like structure,  a clear line of positive 
staining is seen between the surface epithelial cells and the inner 
ball of fibroblastoid cells. Bar, 50 ~m. 
iting cell death and allowing proliferation to proceed in 
dense cell populations, bcl-2 may also facilitate differentia- 
tion in the mammary gland. 
Many  types  of  epithelial  cells,  for  example,  Madin- 
Darby canine kidney cells, thyroid epithelium, and blad- 
der carcinoma cells, can be converted into mesenchymal 
cells both in vivo and in vitro (Boyer et al., 1989; Green- 
burg and Hay, 1988; Zuk et al., 1989). Recent studies have 
demonstrated  that  oncogene  expression can  induce  the 
conversion of mammary epithelial cells to cells with a mes- 
enchymal phenotype in vitro. Thus Reichman et al. (1992) 
reported that activation of the immediate-early gene c-los 
causes  epithelial-fibroblastoid  cell  conversion  and  irre- 
versible loss of epithelial polarity. We have also found that 
overexpression of the c-erbB2 oncogene can induce con- 
version of luminal mammary epithelial cells, (MTSV1-7) 
to fibroblastoid cells (D'Souza et al.,  1993;  D'Souza and 
Taylor-Papadimitriou, 1994). We now show that overex- 
pression of bcl-2 proto-oncogene can also promote the ep- 
ithelial-fibroblastoid  conversion  of  the  same  cell  line. 
However, the biological changes associated with the con- 
version are different between the two oncogene transfec- 
tants in that overexpression of c-erbB2  results in  an an- 
chorage-independent growth and tumorigenicity and loss 
of  morphogenetic  ability,  whereas  cells  overexpressing 
bcl-2  remain  nontumorigenic,  do  not  show  anchorage- 
independent growth and are able to undergo morphogene- 
sis  in vitro. These differences are perhaps not surprising 
since bcl-2 is involved in the regulation of cell death rather 
than cell proliferation and its overexpression has rarely led 
to cells becoming tumorigenic in vitro (Reed et al., 1988). 
On the other hand, it is surprising that some of the bcl-2 
overexpressing clones show a phenotype strikingly similar 
to  the  tumorigenic  c-erbB2  transfectants.  Both  proto- 
oncogenes can induce loss of or reduction in the expres- 
sion  of cell-cell adhesion molecules, namely E-cadherin 
and the tight junction-associated ZO-1 protein. Strikingly, 
both c-erbB2 and bcl-2 transfectants of MTSV1-7 show a 
reduced expression of the 0L2151 integrin which is the major 
integrin expressed by luminal epithelial cells in vivo and 
which  is  crucial  for morphogenesis  in  collagen  in  vitro 
(Berdechevsky et al., 1994). 
The reduced expression of E-cadherin is of particular in- 
terest, since this component plays a central role in main- 
taining epithelial morphology, and reduced expression of 
E-cadherin has been shown to be associated with epithe- 
lial malignancies. E-cadherin can act as an invasion-sup- 
pressor molecule in vitro and cells acquire invasive capa- 
bility  when  treated  with  anti-E-cadherin  antibody  or 
transfected with anti-sense mRNA (Takeichi, 1990; Ulem- 
inckx et al., 1991). A reduction in E-cadherin expression is 
also found in a  proportion of breast carcinomas, particu- 
larly in early stage lesions, and is correlated with invasive- 
hess (Behrens et al.,  1989;  Oka et al.,  1993). The results 
from this study suggest however that although malignant 
behavior is often associated with the reduction or loss of 
E-cadherin expression, down-regulation of this molecule 
does not necessarily lead to a tumorigenic phenotype even 
when, as with the cell line MTSV1-7, the SV40TAg is also 
expressed. 
The change to a mesenchymal phenotype was more evi- 
dent with the transfectants derived from MTSV1-7, which, 
although a  cloned cell line, shows microheterogeneity of 
morphology and appears to show more plasticity of phe- 
notype. Of the HB2 clones isolated, the B9 contained the 
highest  proportion  (10%)  of  vimentin-expressing  cells. 
The HB2 cell line was  selected on matrigel,  and in col- 
lagen,  for  a  uniform  branching  response  to  fibroblast- 
derived growth factors. HB2 cells are more homogeneous 
morphologically and the epithelial phenotype appears to 
be less plastic. Thus the result of overexpressing the bcl-2 
gene on phenotype and morphogenetic behavior appears 
to be strongly dependent on the phenotype of the individ- 
ual cell, which in turn reflects a specific stage of differenti- 
ation in a particular cell lineage. 
The effect of overexpression of Bcl-2 on survival of the 
mammary  epithelial  cell  lines  under  restrictive  growth 
conditions appears to be due to a decrease in the propor- 
tion of cells shed into the medium. Whether the shed cells 
are  dying by apoptosis  is  not  clear since  although  they 
have  fragmented  nuclei,  a  typical ladder  of fragmented 
DNA was not seen. If apoptosis is occurring it is unlikely 
to be mediated by p53 which, in these ceils, is wild type but 
bound by SV40 TAg.  An important consequence of the 
increased cell survival at confluence is  the formation of 
multilayers which can form three-dimensional structures. 
Where  the  differentiation is  pleiotypic, organized struc- 
tures are formed where a layer of epithelial cells surrounds 
a central body of mesenchymal cells, the two cell types be- 
ing  separated  by  a  basement  membrane  like  structure. 
Since the pleiotypic differentiation is more evident with 
the  MTSV1-7 cells,  the  organized  structures  were more 
readily formed by the MTSV1-7 transfectants. However, 
in collagen gels, the HB2 clones showed a more physiolog- 
ical type of branching structure with lumen formation. 
In considering whether the morphologic and phenotypic 
conversion  seen  in  the  Bcl-2  overexpressing  MTSV1-7 
cells reflects an in vivo phenomenon it is relevant to note 
that Bcl-2 has been found to be strongly expressed in the 
epithelial cells of the mammary bud at the early stage of 
morphogenesis  involving  gland  branching  (Lu  et  al., 
Lu et al. bcl-2 and Mammary Epithelial Differentiation  1375 Figure 12.  Morphogenesis  in collagen gel. (A) MTSV1-7Puro; (B) MTSV1-7 B7: (C) MTSV1-7 B1; (D) HB2Puro; (E) HB2 B9, and (F) 
HB2 B6. The puro vector controls grow as ball-like structures.  The MTSV1-7 B1 and B7 show narrow branches,  whereas the HB2 B9 
and B6 have thicker and smoother branches.  Cells were cultured for 14 d in the absence of fibroblast derived factors. Bar, 100 Dxm. 
1993a; Nathan  et al.,  1994).  Also, in the adult gland, the 
maximum level of Bcl-2 expression is seen during the fol- 
licular  phase  of the  menstrual  cycle  when  proliferation 
(accompanied by morphological differentiation) is occur- 
ring. (Sabourin et al., 1994). Certainly branching might be 
expected to be accompanied by a reduction in the strength 
of the  forces holding the  cell to the  extracellular matrix 
and to adjacent cells, and reduced expression of adhesion 
molecules such as the o~2lM integrin and E-cadherin would 
achieve this. Furthermore, the changes in cell shape that 
accompany organ morphogenesis may also require  alter- 
ations in the cytoskeleton of the cell such as those seen in 
The  Journal  of  Cell  Biology,  Volume 129,  1995  1376 the intermediate filaments of the bcl-2 transfectants. It is 
therefore quite possible that the effects of Bcl-2 on the 
growth, differentiation phenotype, and morphogenetic be- 
havior of mammary epithelial cells, which we  have  ob- 
served in vitro, reflect a physiological role of the protein in 
the regulation of growth and morphogenesis of the mam- 
mary gland. 
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